News from the centers


Blood-brain-barrier crossing AAVs available

Back to Overview

You are here:

Go through...

VCF is offering Charité scientists and external academic institutions new modified AAV serotypes which enable the virus to cross the blood brain barrier. By modifying the capsid protein noninvasive gene delivery can be done. You can order new viruses via our online tool.

Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Chan KY et al., Nat Neurosci. 2017 Aug;20(8):1172-1179.


Bettina Brokowski

Responsible for Cell culture maintenance, Virus Production and Virus CharacterisationCharitéUniversitätsmedizin Berlin

Postal address:Charitéplatz 110117 Berlin

Campus / internal address:Virchowweg 6

CCM, Virchowweg 6

Back to Overview